Increased susceptibility to LPS-induced endotoxin shock in secretory leukoprotease inhibitor (SLPI)-deficient mice
about
WFDC1 is a key modulator of inflammatory and wound repair responsesConcordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesionsDietary heme alters microbiota and mucosa of mouse colon without functional changes in host-microbe cross-talk.Changes in salivary proteome following allogeneic hematopoietic stem cell transplantation.Anti-inflammatory and antimicrobial roles of secretory leukocyte protease inhibitor.Expression QTL mapping in regulatory and helper T cells from the BXD family of strains reveals novel cell-specific genes, gene-gene interactions and candidate genes for auto-immune disease.HMGB1 in health and disease.Peptide nanofibers preconditioned with stem cell secretome are renoprotective.Secretory leukocyte protease inhibitor plays an important role in the regulation of allergic asthma in mice.Regulation of mucosal immunity in the female reproductive tract: the role of sex hormones in immune protection against sexually transmitted pathogensHypoxia down-regulates expression of secretory leukocyte protease inhibitor in bronchial epithelial cells via TGF-β1Gut microbiota facilitates dietary heme-induced epithelial hyperproliferation by opening the mucus barrier in colonThe inhibitory effect of secretory leukocyte protease inhibitor (SLPI) on formation of neutrophil extracellular traps.Decreased levels of secretory leucoprotease inhibitor in the Pseudomonas-infected cystic fibrosis lung are due to neutrophil elastase degradation.New Kunitz-Type HCRG Polypeptides from the Sea Anemone Heteractis crispaSyndecan 4 Mediates Nrf2-dependent Expansion of Bronchiolar Progenitors That Protect Against Lung Inflammation.Estradiol selectively regulates innate immune function by polarized human uterine epithelial cells in cultureIkaros Is a Negative Regulator of B1 Cell Development and Function.Protective effects of urinary trypsin inhibitor on systemic inflammatory response induced by lipopolysaccharideInnate host defense functions of secretory leucoprotease inhibitor.Secretory leukocyte peptidase inhibitor and lung cancer.Sex hormone regulation of innate immunity in the female reproductive tract: the role of epithelial cells in balancing reproductive potential with protection against sexually transmitted pathogens.SLPI and elafin: multifunctional antiproteases of the WFDC family.Secretory leucoprotease inhibitor binds to NF-kappaB binding sites in monocytes and inhibits p65 binding.Thymic stromal lymphopoetin-induced expression of the endogenous inhibitory enzyme SLPI mediates recovery from colonic inflammation.Intestinal innate immunity and the pathogenesis of Salmonella enteritis.Stimulation and suppression of innate immune function by American ginseng polysaccharides: biological relevance and identification of bioactives.Paracrine factors of multipotent stromal cells ameliorate lung injury in an elastase-induced emphysema model.ONO 3403, a synthetic serine protease inhibitor, inhibits lipopolysaccharide-induced tumor necrosis factor-{alpha} and nitric oxide production and protects mice from lethal endotoxic shock.Therapy of experimental pseudomonas infections with a nonreplicating genetically modified phage.Innate immune response to lipooligosaccharide: pivotal regulator of the pathobiology of invasive Neisseria meningitidis infections.Antiproteases as therapeutics to target inflammation in cystic fibrosis.IkappaBbeta is an essential co-activator for LPS-induced IL-1beta transcription in vivo.Novel anti-inflammatory role of SLPI in adipose tissue and its regulation by high fat diet.Aged neutrophils contribute to the first line of defense in the acute inflammatory responseSecretory leukocyte protease inhibitor inhibits neutrophil apoptosis.Role of FAN in tumor necrosis factor-alpha and lipopolysaccharide-induced interleukin-6 secretion and lethality in D-galactosamine-sensitized mice.Antileukoproteinase: modulation of neutrophil function and therapeutic effects on anti-type II collagen antibody-induced arthritis.Protective role of urinary trypsin inhibitor in acute lung injury induced by lipopolysaccharide.The secretory leukocyte protease inhibitor (SLPI) and the secondary granule protein lactoferrin are synthesized in myelocytes, colocalize in subcellular fractions of neutrophils, and are coreleased by activated neutrophils.
P2860
Q28505746-66417980-608F-4D96-B490-A6EB0CDA4489Q30909247-01601ADC-FE93-4A88-BE38-0995F17D3093Q31108939-DC69BA47-8015-4E9A-8D1C-D9FDBF29870DQ33270568-CEE497FA-0CA8-4957-B1B9-53C43652F1DEQ33715960-048785F3-9FBE-4B61-9FE7-DB3DBBA8EFB1Q34105794-00847B55-6697-4808-A8BD-78656FBCF07DQ34622835-F2B28C90-41B2-4237-B683-C3D851DBB1DAQ34726874-32962745-6966-4DB2-9F41-647657AC2716Q35014657-9A008219-2A9F-4281-9387-470E005C91E4Q35153994-365A6C28-15D7-454E-A0BC-6D902A3CF004Q35597064-F5AB73D9-2A14-458E-A4E1-66DD747E05A3Q35718030-99985878-3ADF-43C2-9901-A2FF5CDB0A5BQ35741744-7A88571A-CC7D-46FF-BD4E-0A8F4125EC74Q36114167-7B31F713-5EB5-4ED3-BBA2-B34DCBE3872EQ36226721-0529A8E1-68ED-418F-9740-32B10BE99292Q36582808-1D375973-BF93-47AC-8711-38F46CC0D972Q36751036-5CF51410-FA56-42A5-A1F5-FD9E8F6A9B9FQ36884809-44392E4D-6BCE-46E3-A881-2C04762E7511Q36968990-4350838B-0F06-46C1-B499-D2EA6EF726B0Q37030651-B1AB3418-CB4E-4097-9617-9DA43DCBDC8DQ37124951-86A21649-0121-42C8-B415-8B716468A05BQ37334338-CEE5460F-785C-4DED-9B68-5F2121EB416DQ37936541-727A551B-AF56-4E35-8D8B-83683B19ABF4Q38317744-CED67CC8-4A6C-44F2-9CC3-E37F8C0DCEC2Q38354119-24907F66-B3F2-4691-A6DD-1D61814B9149Q38793052-6314E6E6-8A7D-469F-9292-82C429BF26ABQ38957695-E4B35180-163B-4462-B956-12C41F5CDCB7Q39655858-F3A55997-C7FD-4978-B616-82213290A2A0Q39761305-82D39588-F9D9-4EBE-8034-E02396F72A96Q40164333-2D2C2CFD-7F9F-4F17-98A7-D1481AD96250Q40245353-79CB6325-7939-4A1B-B60D-0FA8186DF6DAQ40363808-EA85BB72-2D20-4468-A5CE-ED0EEC17874EQ41676808-0DA21902-2B99-47B7-816F-CBD00B17981AQ41916397-91DA95FB-24B4-4092-AEFC-A9A9BEBCCB20Q42147677-8FE3A989-82A8-486F-BBA7-3D0808CFBDD6Q43554883-FD69E9AE-044E-4AE1-8033-CCF8C75D6461Q44777453-E4572F64-A731-44D9-AC33-3F7C18CE3E93Q44973889-952ED892-449D-469A-A0AF-B45D9F0C0951Q46406279-0695F9A2-29DD-4825-B1BE-AD9748C09DBEQ46745153-234CF39E-CE62-40F0-A57C-72B8FD993102
P2860
Increased susceptibility to LPS-induced endotoxin shock in secretory leukoprotease inhibitor (SLPI)-deficient mice
description
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2003
@ast
im März 2003 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2003/03/03)
@sk
vědecký článek publikovaný v roce 2003
@cs
wetenschappelijk artikel (gepubliceerd op 2003/03/03)
@nl
наукова стаття, опублікована в березні 2003
@uk
مقالة علمية (نشرت في 3-3-2003)
@ar
name
Increased susceptibility to LP ...... nhibitor (SLPI)-deficient mice
@ast
Increased susceptibility to LP ...... nhibitor (SLPI)-deficient mice
@en
Increased susceptibility to LP ...... nhibitor (SLPI)-deficient mice
@nl
type
label
Increased susceptibility to LP ...... nhibitor (SLPI)-deficient mice
@ast
Increased susceptibility to LP ...... nhibitor (SLPI)-deficient mice
@en
Increased susceptibility to LP ...... nhibitor (SLPI)-deficient mice
@nl
prefLabel
Increased susceptibility to LP ...... nhibitor (SLPI)-deficient mice
@ast
Increased susceptibility to LP ...... nhibitor (SLPI)-deficient mice
@en
Increased susceptibility to LP ...... nhibitor (SLPI)-deficient mice
@nl
P2093
P2860
P356
P1476
Increased susceptibility to LP ...... nhibitor (SLPI)-deficient mice
@en
P2093
Akira Nakamura
Koichi Hagiwara
Masahito Ebina
Takayuki Igarashi
Takuji Suzuki
Tatsuya Abe
Tomohiro Sakakibara
Toshiaki Kikuchi
Toshihiro Nukiwa
Toshiyuki Takai
P2860
P304
P356
10.1084/JEM.20021824
P407
P577
2003-03-01T00:00:00Z